Pad Chivukula, Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc. (ARCT), sold 5,000 shares at $18.72 ($94K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($94k) by Chief Scientific Officer & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARCT | SELL | 2024-06-04 | $1.0M | — | Filing → |
| ARCT | SELL | 2024-03-27 | $1.2M | — | Filing → |
| ARCT | SELL | 2024-03-21 | $600K | — | Filing → |